ICUI
What one share of Icu Medical Inc/De holds
Surgical and Medical Instruments and Apparatus
ICU develops, manufactures and sells innovative medical products used in infusion therapy, vascular access, and vital care applications. Our team is focused on providing quality, innovation and value to our clinical customers worldwide.
Icu Medical Inc/De’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $87.13 |
|---|---|
| Profit | $1.21 |
| Capex (buildings and equipment) | $3.37 |
| Free cash flow | $6.17 |
| Cash and investments | $11.93 |
| Debt | $49.48 |
| Book value | $86.05 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $21.99 | $3.66 | $1.35 | $3.86 | — | $40.41 |
| 2017 | $61.97 | $3.29 | $3.57 | $3.83 | — | $59.29 |
| 2018 | $64.81 | $1.33 | $4.29 | $3.12 | — | $61.67 |
| 2019 | $58.77 | $4.69 | $4.52 | $0.21 | — | $66.40 |
| 2020 | $58.87 | $4.02 | $4.26 | $6.06 | — | $71.34 |
| 2021 | $60.43 | $4.74 | $3.15 | $9.14 | — | $75.94 |
| 2022 | $95.53 | −$3.11 | $3.78 | −$6.39 | — | $87.11 |
| 2023 | $93.77 | −$1.23 | $3.48 | $3.42 | — | $87.96 |
| 2024 | $97.67 | −$4.83 | $3.25 | $5.11 | — | $80.16 |
| 2025 | $89.59 | $0.03 | $3.54 | $3.69 | — | $86.03 |